CCOc1ccc(-c2c(=O)n(OCc3nc4ccccc4[nH]3)c3ccccc3[n+]2[O-])cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?